Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced Dose of Activated Charcoal on Rivaroxaban PK (RICHAR2)
NCT04767776Phase 1Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Jan 2022
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of activated charcoal in Anticoagulant rodenticide poisoning (ARP), sponsored by CHU Saint-Etienne. Started Jan 2022; status: completed.
02
Drugs
activated charcoal
03
Conditions
Anticoagulant rodenticide poisoning (ARP)
Beyond the preview
Go deeper on NCT04767776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04767776.